Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg [Phase 1]

View source ↗

Summary

Phase 1 study assessing the relative bioavailability of Alprazolam 2 mg tablets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

Sponsor: Sandoz | Conditions: Anxiety | Phase 1 | Status: COMPLETED